ClinicalTrialsFinder
RecruitingNCT01608152

Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors

Sponsor

M.D. Anderson Cancer Center

Enrollment

40 participants

Start Date

Feb 20, 2013

Study Type

OBSERVATIONAL

Conditions

LymphomaLeukemia

Summary

This trial collects feedback from patients to develop a video game in improving the outcomes in stem cell transplant survivors. A video game may help to improve health behaviors for leukemia or lymphoma patients after stem cell transplant.

Eligibility

Min Age: 15 YearsMax Age: 39 Years

Inclusion Criteria12

  • Phase I
  • The target population for this study will consist of:
  • Individuals ages 15-29
  • Able to read and speak English
  • Diagnosis of leukemia or lymphoma
  • First time allogeneic SCT recipient
  • Phase II
  • The target population for this study will consist of:
  • Individuals ages 18-39 (in phase I, we recruited only individuals age 15-29. For phase II, we will recruit young adults, and will expand the eligible age range up to 39 years. This expansion in age eligibility to 39 years is consistent with the National Cancer Institute definition of adolescents and young adults with cancer, and is consistent with the age range of patients seen at MD Anderson in the Adolescent and Young Adult Center.
  • Able to read and speak English
  • Diagnosis of leukemia or lymphoma (including Myelodysplastic Syndrome - MDS) or lymphoma
  • HSCT recipient

Exclusion Criteria11

  • Phase I
  • The target population will be excluded if:
  • They do not speak English
  • They have vision problems
  • They have cognitive problems
  • They have psychological difficulties
  • Phase II
  • The target population will be excluded if:
  • They do not speak English
  • They have vision problems that would preclude them from viewing a computer screen.
  • They have an intellectual deficiency that would prevent the potential participant from understanding information delivered on the computer platform or as defined by the DSM-V Diagnostic and Statistical Manual of Mental Disorders that would prevent them from understanding information delivered on the computer platform.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFocus Group

Attend a focus group

OTHERInternet-Based Intervention

Have access to the game

BEHAVIORALInterview

1 week after the 3-week period ends, interview conducted over the phone or at a clinic visit.

Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01608152

Related Trials

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT014410891 location

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

NCT032585671 location

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT052379863 locations

A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

NCT0652273744 locations

Sample Collection and Tracking for the Developmental Therapeutics Clinic

NCT032695781 location